• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,935.00(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glenmark Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20600.0
  • ISIN : INE935A01035
1,360.70 -60 (-4.24%)
  • As on 26 Apr 2025 (EOD)

  • Today’s Low

    1,355.00

  • Today’s High

    1,434.40

  • Open

    1,421.20

  • Perv Close

    1,420.90

  • 52W Low

    985.20

  • 52W High

    1,830.95

Key Indicators

  • P/E(TTM)

    16.64

  • Mar.Cap (₹Cr.)

    38,397.34

  • Div & Yield %

    0.18

  • Book Value(₹)

    848.58

  • Debt-Equity Ratio

    -4.24

  • AGM Date

    25-Apr-2025

  • EPS

    81.65

  • P/E Ratio

    16.64

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    38,397.34

  • RONW (%)

    -50.87

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    28.22

  • BV (₹)

    848.60

  • Sales( ₹ in Cr.)

    7,891.12

  • NP (in Cr.)

    1,425.03

  • NP Var(%)

    -10.0

  • Div%

    250.0

  • CPS (₹)

    57.70

  • EPS (₹)

    50.50

  • Traded Value (₹ in Lakhs)

    38,346.55

  • 52 Week High

    1,830.95

  • 52 Week Low

    985.20

  • Price BSE

    1359.0

  • Price NSE

    1,361.00

  • Market Capital( in Cr.)

    38,346.55

  • P/C Ratio

    23.60

  • P/E Ratio

    26.90

  • Price Vs.BV

    50.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7,891.12 8,220.66 8,141.58 7,567.93 6,712.63 6,304.87
Other Income 6,238.36 985.94 1,044.96 470.13 625.34 954.61
Stock Adjustments 103.07 31.37 16.13 -5.24 -48.77 -471.81
Total Income 14,232.55 9,237.97 9,202.67 8,032.82 7,289.20 6,787.67
EXPENDITURE :            
Raw Materials 3,313.19 3,427.07 3,474.66 2,944.53 2,617.22 1,887.15
Power and Fuel Cost 104.92 95.09 91.34 80.49 90.76 82.99
Employee Cost 1,434.78 1,346.51 1,193.20 1,107.40 1,072.33 969.98
Other Manufacturing Expenses 375.32 304.66 297.44 267.26 230.03 218.75
Selling and Administration Expenses 1,199.17 1,246.10 1,062.89 914.37 977.77 992.83
Miscellaneous Expenses 325.15 855.71 349.97 358.30 371.53 353.89
Employee Benefit Expenses 1,434.78 1,346.51 1,193.20 1,107.40 1,072.33 969.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,752.52 7,275.13 6,469.50 5,672.35 5,359.63 4,505.58
Operating Profit 7,480.02 1,962.84 2,733.18 2,360.47 1,929.57 2,282.08
Interest 277.11 206.82 236.04 265.90 256.39 223.81
Gross Profit 7,202.91 1,756.02 2,497.14 2,094.57 1,673.18 2,058.27
Depreciation 202.16 184.15 159.70 150.82 138.54 106.28
Profit Before Tax 7,000.75 1,571.87 2,337.44 1,943.75 1,534.64 1,951.99
Current Tax 1,049.99 386.93 411.08 343.62 269.24 383.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 783.46 -23.83 -71.42 -49.31 -89.14 -53.61
Reported Net Profit 5,167.29 1,208.77 1,997.79 1,649.45 1,354.55 1,622.11
Extraordinary Items 3,742.26 -369.56 354.02 59.87 14.43 277.16
Adjusted Net Profit 1,425.03 1,578.33 1,643.77 1,589.58 1,340.12 1,344.95
Adjustment below Net Profit -4.76 0.63 1.61 2.48 -5.42 -3.54
P & L Balance brought forward 16,002.82 14,863.96 12,921.86 11,340.47 10,059.38 8,508.84
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 77.22 70.54 57.30 70.54 68.03 68.03
P & L Balance carried down 21,088.13 16,002.82 14,863.96 12,921.86 11,340.47 10,059.38
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 250.00 250.00 250.00 250.00 250.00 200.00
Dividend Per Share(Rs) 2.50 2.50 2.50 2.50 2.50 2.00
Earnings Per Share-Unit Curr 183.11 42.84 70.80 58.46 48.00 57.49
Earnings Per Share(Adj)-Unit Curr 183.11 42.84 70.80 58.46 48.00 57.49
Book Value 814.01 633.57 593.21 524.84 468.73 423.22
Book Value(Adj)-Unit Curr 814.01 633.57 593.21 524.84 468.73 423.22

Shareholding Pattern

  • Promoter Group

    46.65%

  • Public Share Holding

    53.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,391,001 1.20 3,391,001 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 128,241,936 45.45 128,241,936 1
Others 0 0.00 0 0
Sub Total 131,632,937 46.65 131,632,937 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 107,631 0.04 107,631 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,090 0.00 2,090 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 65,350,743 23.16 65,350,743 347
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,214,466 0.43 1,214,466 14
Mutual Funds / UTI 36,291,337 12.86 36,291,337 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,693,391 1.31 3,693,391 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 106,659,658 37.80 106,659,658 404
2] Non Institution
Bodies Corporate 6,156,945 2.18 6,156,945 831
Clearing Members 504 0.00 504 4
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,113,344 0.75 2,109,344 4,784
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 520,115 0.18 520,115 3,290
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,055,196 4.63 12,455,196 16
Individuals holding nominal share capital up to Rs. 1 lakh 21,699,180 7.69 21,469,346 183,376
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 59,007 0.02 59,007 9
Others 290,670 0.10 290,670 3
Sub Total 43,895,561 15.56 43,061,727 192,314
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,188,156 100.00 281,354,322 192,724

Company Background

Glenmark Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Glenmark Pharmaceuticals Ltd
  • BSE Code : 20600.0
  • ISIN : INE935A01035

  • Incorporation Year

    1977

  • Registered Office

    B/2 Mahalaxmi Chambers
    22 Bhulabhai Desai Road, Mumbai,
    Maharashtra-400026

  • Telephone

    91-22-40189999

  • FAX

    91-22-40189986

  • Chairman

    Glenn Saldanha

  • Managing Director

    Glenn Saldanha

  • Company Secretary

  • Auditor

    Suresh Surana & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glenmark Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glenmark Pharma. 1,358.90 9,059.14 7,891.12 6.31 9.75
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92